|
1
|
Ito Y: Oncogenic potential of the RUNX
gene family: 'overview'. Oncogene. 23:4198–4208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chuang LS, Ito K and Ito Y: RUNX family:
Regulation and diversification of roles through interacting
proteins. Int J Cancer. 132:1260–1271. 2013. View Article : Google Scholar
|
|
3
|
Miyazono K, Maeda S and Imamura T:
Coordinate regulation of cell growth and differentiation by
TGF-beta superfamily and Runx proteins. Oncogene. 23:4232–4237.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stifani S and Ma Q: 'Runxs and
regulations' of sensory and motor neuron subtype differentiation:
Implications for hematopoietic development. Blood Cells Mol Dis.
43:20–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chuang LS and Ito Y: RUNX3 is
multifunctional in carcinogenesis of multiple solid tumors.
Oncogene. 29:2605–2615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee SH, Kim J, Kim WH and Lee YM: Hypoxic
silencing of tumor suppressor RUNX3 by histone modification in
gastric cancer cells. Oncogene. 28:184–194. 2009. View Article : Google Scholar
|
|
7
|
Patan S: Vasculogenesis and angiogenesis.
Cancer Treat Res. 117:3–32. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Urbich C and Dimmeler S: Endothelial
progenitor cells: Characterization and role in vascular biology.
Circ Res. 95:343–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Asahara T and Kawamoto A: Endothelial
progenitor cells for postnatal vasculogenesis. Am J Physiol Cell
Physiol. 287:C572–C579. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moschetta M, Mishima Y, Sahin I, Manier S,
Glavey S, Vacca A, Roccaro AM and Ghobrial IM: Role of endothelial
progenitor cells in cancer progression. Biochim Biophys Acta.
1846:26–39. 2014.PubMed/NCBI
|
|
11
|
Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi
JS, Bambino K, Gupta S, Heikamp E, McDevitt MR, Scheinberg DA,
Benezra R, et al: Bone marrow-derived endothelial progenitor cells
are a major determinant of nascent tumor neovascularization. Genes
Dev. 21:1546–1558. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Obi S, Yamamoto K, Shimizu N, Kumagaya S,
Masumura T, Sokabe T, Asahara T and Ando J: Fluid shear stress
induces arterial differentiation of endothelial progenitor cells. J
Appl Physiol (1985). 106:203–211. 2009. View Article : Google Scholar
|
|
13
|
Masuda H, Alev C, Akimaru H, Ito R,
Shizuno T, Kobori M, Horii M, Ishihara T, Isobe K, Isozaki M, et
al: Methodological development of a clonogenic assay to determine
endothelial progenitor cell potential. Circ Res. 109:20–37. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwon SM, Lee YK, Yokoyama A, Jung SY,
Masuda H, Kawamoto A, Lee YM and Asahara T: Differential activity
of bone marrow hematopoietic stem cell subpopulations for EPC
development and ischemic neovascularization. J Mol Cell Cardiol.
51:308–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hur J, Yang HM, Yoon CH, Lee CS, Park KW,
Kim JH, Kim TY, Kim JY, Kang HJ, Chae IH, et al: Identification of
a novel role of T cells in postnatal vasculogenesis:
Characterization of endothelial progenitor cell colonies.
Circulation. 116:1671–1682. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalka C, Masuda H, Takahashi T, Kalka-Moll
WM, Silver M, Kearney M, Li T, Isner JM and Asahara T:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA.
97:3422–3427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schwarz TM, Leicht SF, Radic T,
Rodriguez-Arabaolaza I, Hermann PC, Berger F, Saif J, Böcker W,
Ellwart JW, Aicher A, et al: Vascular incorporation of endothelial
colony-forming cells is essential for functional recovery of murine
ischemic tissue following cell therapy. Arterioscler Thromb Vasc
Biol. 32:e13–e21. 2012. View Article : Google Scholar
|
|
18
|
Lee SH, Lee JH, Han YS, Ryu JM, Yoon YM
and Han HJ: Hypoxia accelerates vascular repair of endothelial
colony-forming cells on ischemic injury via STAT3-BCL3 axis. Stem
Cell Res Ther. 6:1392015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moccia F, Zuccolo E, Poletto V, Cinelli M,
Bonetti E, Guerra G and Rosti V: Endothelial progenitor cells
support tumour growth and metastatisation: Implications for the
resistance to anti-angiogenic therapy. Tumour Biol. 36:6603–6614.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee SH, Bae SC, Kim KW and Lee YM: RUNX3
inhibits hypoxia-inducible factor-1α protein stability by
interacting with prolyl hydroxylases in gastric cancer cells.
Oncogene. 33:1458–1467. 2014. View Article : Google Scholar
|
|
21
|
Choi JH, Nguyen MP, Lee D, Oh GT and Lee
YM: Hypoxia-induced endothelial progenitor cell function is blunted
in angiotensinogen knockout mice. Mol Cells. 37:487–496. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Benito J, Zeng Z, Konopleva M and Wilson
WR: Targeting hypoxia in the leukemia microenvironment. Int J
Hematol Oncol. 2:279–288. 2013. View Article : Google Scholar
|
|
23
|
Gaidzik VI, Teleanu V, Papaemmanuil E,
Weber D, Paschka P, Hahn J, Wallrabenstein T, Kolbinger B, Köhne
CH, Horst HA, et al: RUNX1 mutations in acute myeloid leukemia are
associated with distinct clinicopathologic and genetic features.
Leukemia. 30:2160–2168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li QL, Ito K, Sakakura C, Fukamachi H,
Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, et al: Causal
relationship between the loss of RUNX3 expression and gastric
cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kwon SM, Eguchi M, Wada M, Iwami Y, Hozumi
K, Iwaguro H, Masuda H, Kawamoto A and Asahara T: Specific Jagged-1
signal from bone marrow microenvironment is required for
endothelial progenitor cell development for neovascularization.
Circulation. 118:157–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tanaka R, Wada M, Kwon SM, Masuda H, Carr
J, Ito R, Miyasaka M, Warren SM, Asahara T and Tepper OM: The
effects of flap ischemia on normal and diabetic progenitor cell
function. Plast Reconstr Surg. 121:1929–1942. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Choi JH, Nguyen MP, Jung SY, Kwon SM, Jee
JG, Bae JS, Lee S, Lee MY and Lee YM: Inhibitory effect of
glyceollins on vasculogenesis through suppression of endothelial
progenitor cell function. Mol Nutr Food Res. 57:1762–1771.
2013.PubMed/NCBI
|
|
28
|
Nguyen MP, Lee D, Lee SH, Lee HE, Lee HY
and Lee YM: Deguelin inhibits vasculogenic function of endothelial
progenitor cells in tumor progression and metastasis via
suppression of focal adhesion. Oncotarget. 6:16588–16600. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Biscetti F, Straface G, Arena V, Stigliano
E, Pecorini G, Rizzo P, De Angelis G, Iuliano L, Ghirlanda G and
Flex A: Pioglitazone enhances collateral blood flow in ischemic
hindlimb of diabetic mice through an Akt-dependent VEGF-mediated
mechanism, regardless of PPARgamma stimulation. Cardiovasc
Diabetol. 8:492009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamaguchi J, Kusano KF, Masuo O, Kawamoto
A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner
JM, et al: Stromal cell-derived factor-1 effects on ex vivo
expanded endothelial progenitor cell recruitment for ischemic
neovascularization. Circulation. 107:1322–1328. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kucia M, Jankowski K, Reca R, Wysoczynski
M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J and Ratajczak MZ:
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol
Histol. 35:233–245. 2004. View Article : Google Scholar
|
|
32
|
Okabe S, Fukuda S, Kim YJ, Niki M, Pelus
LM, Ohyashiki K, Pandolfi PP and Broxmeyer HE: Stromal cell-derived
factor-1alpha/CXCL12-induced chemotaxis of T cells involves
activation of the RasGAP-associated docking protein p62Dok-1.
Blood. 105:474–480. 2005. View Article : Google Scholar
|
|
33
|
Matsumoto T and Claesson-Welsh L: VEGF
receptor signal transduction. Sci STKE. 2001:re212001.PubMed/NCBI
|
|
34
|
Zheng H, Fu G, Dai T and Huang H:
Migration of endothelial progenitor cells mediated by stromal
cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal
transduction pathway. J Cardiovasc Pharmacol. 50:274–280. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Llevadot J and Asahara T: Effects of
statins on angiogenesis and vasculogenesis. Rev Esp Cardiol.
55:838–844. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ramakrishnan S, Anand V and Roy S:
Vascular endothelial growth factor signaling in hypoxia and
inflammation. J Neuroimmune Pharmacol. 9:142–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu Y, Jin M, Xu H, Shimin Z, He S, Wang L
and Zhang Y: Clinicopathologic significance of HIF-1α, CXCR4, and
VEGF expression in colon cancer. Clin Dev Immunol. 2010:5375312010.
View Article : Google Scholar
|
|
38
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Iwami Y, Masuda H and Asahara T:
Endothelial progenitor cells: Past, state of the art, and future. J
Cell Mol Med. 8:488–497. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Asahara T, Kawamoto A and Masuda H:
Concise review: Circulating endothelial progenitor cells for
vascular medicine. Stem Cells. 29:1650–1655. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Peng Z, Wei D, Wang L, Tang H, Zhang J, Le
X, Jia Z, Li Q and Xie K: RUNX3 inhibits the expression of vascular
endothelial growth factor and reduces the angiogenesis, growth, and
metastasis of human gastric cancer. Clin Cancer Res. 12:6386–6394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Takakura N, Watanabe T, Suenobu S, Yamada
Y, Noda T, Ito Y, Satake M and Suda T: A role for hematopoietic
stem cells in promoting angiogenesis. Cell. 102:199–209. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ter Elst A, Ma B, Scherpen FJ, de Jonge
HJ, Douwes J, Wierenga AT, Schuringa JJ, Kamps WA and de Bont ES:
Repression of vascular endothelial growth factor expression by the
runt-related transcription factor 1 in acute myeloid leukemia.
Cancer Res. 71:2761–2771. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kalev-Zylinska ML, Horsfield JA, Flores
MV, Postlethwait JH, Vitas MR, Baas AM, Crosier PS and Crosier KE:
Runx1 is required for zebrafish blood and vessel development and
expression of a human RUNX1-CBF2T1 transgene advances a model for
studies of leukemogenesis. Development. 129:2015–2030.
2002.PubMed/NCBI
|
|
45
|
Spender LC, Whiteman HJ, Karstegl CE and
Farrell PJ: Transcriptional cross-regulation of RUNX1 by RUNX3 in
human B cells. Oncogene. 24:1873–1881. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Medina RJ, O'Neill CL, Sweeney M,
Guduric-Fuchs J, Gardiner TA, Simpson DA and Stitt AW: Molecular
analysis of endothelial progenitor cell (EPC) subtypes reveals two
distinct cell populations with different identities. BMC Med
Genomics. 3:182010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fainaru O, Shseyov D, Hantisteanu S and
Groner Y: Accelerated chemokine receptor 7-mediated dendritic cell
migration in Runx3 knockout mice and the spontaneous development of
asthma-like disease. Proc Natl Acad Sci USA. 102:10598–10603. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ehlers M, Laule-Kilian K, Petter M,
Aldrian CJ, Grueter B, Würch A, Yoshida N, Watanabe T, Satake M and
Steimle V: Morpholino antisense oligonucleotide-mediated gene
knockdown during thymocyte development reveals role for Runx3
transcription factor in CD4 silencing during development of
CD4-/CD8+ thymocytes. J Immunol. 171:3594–3604. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Taniuchi I, Osato M, Egawa T, Sunshine MJ,
Bae SC, Komori T, Ito Y and Littman DR: Differential requirements
for Runx proteins in CD4 repression and epigenetic silencing during
T lymphocyte development. Cell. 111:621–633. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Le XF, Groner Y, Kornblau SM, Gu Y,
Hittelman WN, Levanon D, Mehta K, Arlinghaus RB and Chang KS:
Regulation of AML2/CBFA3 in hematopoietic cells through the
retinoic acid receptor alpha-dependent signaling pathway. J Biol
Chem. 274:21651–21658. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gomes I, Sharma TT, Edassery S, Fulton N,
Mar BG and Westbrook CA: Novel transcription factors in human CD34
antigen-positive hematopoietic cells. Blood. 100:107–119. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Leone AM, Valgimigli M, Giannico MB,
Zaccone V, Perfetti M, D'Amario D, Rebuzzi AG and Crea F: From bone
marrow to the arterial wall: The ongoing tale of endothelial
progenitor cells. Eur Heart J. 30:890–899. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Asahara T, Takahashi T, Masuda H, Kalka C,
Chen D, Iwaguro H, Inai Y, Silver M and Isner JM: VEGF contributes
to postnatal neovascularization by mobilizing bone marrow-derived
endothelial progenitor cells. EMBO J. 18:3964–3972. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
